镰状细胞病的肌肉骨骼表现:影像学视角
本文综述镰状细胞病肌肉骨骼并发症的病理生理与影像表现,涵盖骨髓增生、骨梗死、骨坏死、肌坏死及感染。提出骨膜下积液深度≥4 mm并结合炎症标志物和白细胞升高更提示骨髓炎而非单纯骨梗死,MR无增强T1加权抑脂序列鉴别价值尚有争议,DIXON技术通过单次采集无创评估骨髓脂肪分数展现前景。
要点
- 骨膜下积液深度≥4 mm合并炎症标志物及白细胞升高更提示骨髓炎而非单纯骨梗死。
- MR无增强T1加权抑脂序列用于鉴别骨髓炎与骨梗死曾被提出,但结果尚有争议。
- DIXON技术可单次采集无创评估骨髓脂肪分数,作为镰状细胞病疾病负担的生物标志物展现前景。
核心结论
- 镰状细胞病肌肉骨骼并发症与溶血性贫血所致骨髓增生及血管闭塞所致骨梗死、骨坏死、肌坏死和感染相关,急性骨髓炎与骨梗死的鉴别仍是临床和影像挑战,需多学科协作。
研究设计与样本
- 综述,检索范围与纳入文献原文未报告。
关键影像表现/征象
- 溶血和贫血导致骨髓增生和髓外造血。
- 血管闭塞导致骨坏死/骨梗死、肌坏死和感染(骨髓炎和化脓性关节炎)。
- 大骨膜下积液(深度≥4 mm)合并炎症标志物和白细胞计数升高更提示骨髓炎而非单纯骨梗死。
- MR无增强T1加权抑脂序列曾被提出用于鉴别骨髓炎与骨梗死,但迄今结果尚有争议。
诊断标准与关键数值
- 骨膜下积液深度≥4 mm并结合炎症标志物和白细胞计数升高,更提示骨髓炎而非单纯骨梗死。
临床应用与阅片要点
- 了解镰状细胞病的病理生理和临床表现对影像判读至关重要。
- 急性骨髓炎与骨梗死的鉴别需多学科协作。
- MR DIXON技术通过单次采集无创评估骨髓脂肪分数,已显示作为镰状细胞病疾病负担生物标志物的前景。
局限性
- MR无增强T1加权抑脂序列用于鉴别骨髓炎与骨梗死的结果迄今尚有争议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Sickle cell disease (SCD) is a spectrum of inherited blood disorders, leading to propensity to sickling disruption of red blood cells. Musculoskeletal complications are a common cause of acute and chronic morbidities, related to the main pathophysiological processes: (i) hemolysis and anemia, resulting in marrow hyperplasia and extramedullary hematopoiesis; and (ii) vaso-occlusion, leading to osteonecrosis/bone infarction, myonecrosis, and infection (osteomyelitis and septic arthritis). Knowing the pathophysiology and clinical manifestations is essential for imaging interpretation, but differentiation between acute osteomyelitis and bone infarction remains a clinical and imaging challenge, therefore requiring a multidisciplinary approach. Large subperiosteal fluid collections (≥ 4 mm in depth), in conjunction with elevated inflammatory markers and white blood counts, are more suggestive of osteomyelitis rather than isolated bone infarction. The unenhanced T1-weighted fat-suppressed sequence on MR images was also proposed to aid in this differentiation, but so far with controversial results. Future perspectives of MR imaging include the DIXON technique, which has shown promising results as a biomarker of morbidity of SCD, through evaluation of fat fraction (FF) of bone marrow in a single acquisition and noninvasive way.
引用
- Sato VN, Moriwaki TL, Tsuji LK, et al. Musculoskeletal manifestations of sickle cell disease: an imaging perspective. Skeletal Radiol. 2025. PMID: 40542898. doi:10.1007/s00256-025-04975-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。